Herbalife And The Post-MLM Blues
Rogier van Vlissingen - at Seeking Alpha - Fri Feb 13, 12:19PM CST
HLF: 32.78 (-0.84), IEP: 100.21 (+0.28), BRK.A: 222,555.00 (-1,905.00)
Ackman vs. Icahn: How Two Billionaires, Former Adversaries, Stack Up
at The Street - Fri Feb 13, 10:14AM CST
More than two years have passed since Icahn and Ackman's epic CNBC blowout. Though they've since called a truce, it's worth looking at how these two billionaires stack up today.
AGN: 229.49 (+1.87), HLF: 32.78 (-0.84), VRX: 167.00 (-0.50), ACT: 285.37 (+3.71), EBAY: 56.47 (+1.73), GCI: 34.77 (-0.07), IEP: 100.21 (+0.28), MTW: 21.86 (+0.34), AAPL: 127.08 (+0.62)
Herbalife's Cash Expected To Be Reduced By Latest Venezuela Exchange Rate
Paul Kindzia - at Seeking Alpha - Fri Feb 13, 7:18AM CST
HLF: 32.78 (-0.84)
Herbalife Sponsors the United States Hispanic Leadership Institute's 33rd National Conference
Business Wire - Thu Feb 12, 9:00AM CST
Global nutrition company, Herbalife Ltd. (NYSE: HLF), is proud to sponsor the United States Hispanic Leadership Institute's 33rd National Conference, which begins today in Chicago.
HLF: 32.78 (-0.84)
NY Post Article Highlights Absurdity Of Herbalife Situation: It's Time For Government To Act
Matt Stewart - at Seeking Alpha - Thu Feb 12, 8:11AM CST
HLF: 32.78 (-0.84)
Ten Tips for Maintaining a Healthy Heart
Business Wire - Wed Feb 11, 3:17PM CST
Herbalife's (NYSE: HLF) director of nutrition training and registered dietitian, Susan Bowerman, MS, RD, CSSD, FAND, offers ten tips to keep your heart healthy during Heart Health Month.
HLF: 32.78 (-0.84)
FTC chief OK to share stage with Herbalife exec riles prominent critic
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 9:50AM CST
HLF: 32.78 (-0.84)
Sports and Fitness Nutrition Supplements - Global Strategic Business Report 2015
M2 - Wed Feb 11, 4:19AM CST
Research and Markets (http://www.researchandmarkets.com/research/kzpfhr/sports_and) has announced the addition of the "Sports and Fitness Nutrition Supplements - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Sports and Fitness Nutrition Supplements in US$ Thousands by the following Segments: - Amino Acids/Derivatives - Herbal Products - Vitamins/Minerals - Others Company profiles are primarily based on public domain information including company URLs. The report profiles 237 companies including many key and niche players such as: - Abbott Laboratories Inc. (US) - Champion Nutrition, Inc. (US) - Clif Bar & Company (US) - Dymatize Enterprises, Inc. (US) - Glanbia Plc (Ireland) - Optimum Nutrition, Inc. (US) - GlaxoSmithKline Plc (UK) - GNC Holdings, Inc. (US) - Herbalife International, Inc. (US) - NBTY, Inc. (US) - The Balance Bar Company (US) - Nestl? SA (Switzerland) - Otsuka Pharmaceutical Co., Ltd. (Japan) - PepsiCo Inc. (US) - Red Bull GmbH (Austria) - The Coca-Cola Co. (US) - Yakult Honsha Co., Ltd. (Japan) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. MARKET DYNAMICS 3. TRENDS AND ISSUES 4. PRODUCT INNOVATIONS: A CLOSER LOOK 5. PRODUCT OVERVIEW 6. PRODUCT INTRODUCTIONS/LAUNCHES 7. RECENT INDUSTRY ACTIVITY 8. FOCUS ON SELECT GLOBAL PLAYERS 9. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 237 (including Divisions/Subsidiaries 253) - The United States (173) - Canada (9) - Japan (3) - Europe (48) - France (2) - Germany (2) - The United Kingdom (30) - Rest of Europe (14) - Asia-Pacific (Excluding Japan) (15) - Latin America (1) - Africa (4) For more information visit http://www.researchandmarkets.com/research/kzpfhr/sports_and
HLF: 32.78 (-0.84), ABT: 46.09 (+0.87), GSK: 47.94 (+1.99), PEP: 99.13 (-1.14)
Anatomy Of A Short (Or Long) Part 7 - A Live Case Study Using Herbalife - Other Liabilities And Related Parties
Paul Kindzia - at Seeking Alpha - Tue Feb 10, 10:18AM CST
HLF: 32.78 (-0.84)
Herbalife off on Venezuela currency devaluation
Seeking Alpha - at Seeking Alpha - Tue Feb 10, 9:32AM CST
HLF: 32.78 (-0.84)
Why Investors Who Listen To Tim Ramey Will Get Their Capital Churned
Matt Stewart - at Seeking Alpha - Tue Feb 10, 2:08AM CST
HLF: 32.78 (-0.84)
Anatomy Of A Short (Or Long) Part 6 - A Live Case Study Using Herbalife - Stewards Of Capital
Paul Kindzia - at Seeking Alpha - Mon Feb 09, 7:31AM CST
HLF: 32.78 (-0.84)
Rite Aid Launches 24 RediClinics within Pharmacies - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 05, 5:18PM CST
Rite Aid (RAD) announced the opening of its first set of RediClinics.
HLF: 32.78 (-0.84), WBA: 78.73 (-1.23), CVS: 102.63 (-0.37), RAD: 8.34 (+0.25)
Herbalife Shares Down 12.9% Since SmarTrend's Sell Call (HLF)
Comtex SmarTrend(R) - Thu Feb 05, 11:20AM CST
SmarTrend identified a Downtrend for Herbalife (NYSE:HLF) on December 16th, 2014 at $37.54. In approximately 2 months, Herbalife has returned 12.87% as of today's recent price of $32.71.
HLF: 32.78 (-0.84)
Anatomy Of A Short (Or Long) Part 5 - A Live Case Study Using Herbalife - Net Profit Margins
Paul Kindzia - at Seeking Alpha - Thu Feb 05, 7:15AM CST
HLF: 32.78 (-0.84)
Red Flags In Herbalife's Shipping And Handling Revenues
Matthew Handley - at Seeking Alpha - Wed Feb 04, 9:32AM CST
HLF: 32.78 (-0.84)
Earth Science Tech Building A Nutrition Empire Based On High Grade CBD and Nutraceutical Retailing
ACCESSWIRE - Wed Feb 04, 8:11AM CST
WHITEFISH, MT / ACCESSWIRE / February 4, 2015 / Earth Science Tech (OTC: ETST) has been making excellent progress validating the efficacy of their proprietary CBD (cannabidiol) Rich Hemp Oil product lately via work done at the University of Central Oklahoma, carried out under the visionary eye of the university's Assistant Dean of the College of Mathematics & Science, world-renown scientist and researcher Dr. Wei R. Chen. Following up on initial preliminary testing in animal breast cancer last year, which showed that the appropriate dosages could indeed inhibit cancer cell proliferation at a significant rate, subsequent research into the product's ability to bolster the body's immune system by stimulating the production of a key cytokine (TNF-alpha, a signaling protein) in macrophages ("big eater" white blood cells that engulf and digest things like microbes and cancer cells), has now produced promising results as well.
HLF: 32.78 (-0.84), CARA: 10.96 (-0.03), INSY: 51.50 (-0.66), NATR: 14.18 (-0.04), GWPH: 78.09 (+1.70)
Anatomy Of A Short (Or Long) Part 4 - A Live Case Study Using Herbalife - Gross Profit Margins
Paul Kindzia - at Seeking Alpha - Wed Feb 04, 3:58AM CST
HLF: 32.78 (-0.84)
What's in Store for Nu Skin (NUS) this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 03, 2:00PM CST
Nu-Skin Enterprises, Inc. (NUS) is set to report fourth-quarter 2014 results on Feb 5 before the market opens. Last quarter, the company posted a positive earnings surprise of 20.43%. Let us see how things are shaping up for this announcement.
HLF: 32.78 (-0.84), SVU: 10.21 (+0.04), NUS: 56.92 (-1.30), TSN: 40.70 (-0.09)
Uncovering Herbalife's Suspected Illegal Operations In China
Sagar Joshi - at Seeking Alpha - Tue Feb 03, 10:30AM CST
HLF: 32.78 (-0.84), AVP: 9.08 (+0.39), NUS: 56.92 (-1.30)